Catalyst Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 08/12/2025 | 18.90 M | $410.14 M | 0.51% | 15.47% |
VANGUARD GROUP INC | 08/11/2025 | 8.77 M | $190.22 M | 3.18% | 7.18% |
STATE STREET CORP | 08/14/2025 | 5.48 M | $118.88 M | -0.94% | 4.48% |
RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 3.25 M | $70.56 M | 9.99% | 2.66% |
MORGAN STANLEY | 08/15/2025 | 3.18 M | $69.08 M | 32.95% | 2.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2025 | 2.88 M | $62.48 M | -15.86% | 2.36% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 2.87 M | $62.21 M | 3.66% | 2.35% |
FUNDSMITH LLP | 08/14/2025 | 2.71 M | $58.79 M | 25.93% | 2.22% |
GOLDMAN SACHS GROUP INC | 08/14/2025 | 2.41 M | $52.33 M | -23.08% | 1.97% |
BANK OF AMERICA CORP /DE/ | 08/14/2025 | 2.37 M | $51.34 M | 30.59% | 1.94% |
DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 1.91 M | $41.39 M | -12.80% | 1.56% |
AMERICAN CENTURY COMPANIES INC | 08/12/2025 | 1.76 M | $38.15 M | 233.86% | 1.44% |
ROYCE & ASSOCIATES LP | 08/11/2025 | 1.58 M | $34.35 M | -0.97% | 1.30% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 1.44 M | $31.16 M | 8.24% | 1.18% |
BOSTON PARTNERS | 08/12/2025 | 1.28 M | $27.93 M | 0.58% | 1.05% |
NORTHERN TRUST CORP | 08/13/2025 | 1.28 M | $27.67 M | -14.20% | 1.04% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2025 | 1.22 M | $26.55 M | 18.22% | 1.00% |
INVESCO LTD. | 08/13/2025 | 1.21 M | $26.34 M | 1.17% | 0.99% |
ALLIANZ ASSET MANAGEMENT GMBH | 07/28/2025 | 1.04 M | $22.52 M | 49.51% | 0.85% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2025 | 1.01 M | $22.01 M | 33.42% | 0.83% |
KENNEDY CAPITAL MANAGEMENT LLC | 08/13/2025 | 1.01 M | $21.91 M | -4.89% | 0.83% |
NUVEEN, LLC | 08/12/2025 | 986.27 K | $21.40 M | 28.42% | 0.81% |
MACQUARIE GROUP LTD | 08/14/2025 | 905.29 K | $19.65 M | -3.14% | 0.74% |
RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 845.05 K | $18.34 M | 91.83% | 0.69% |
UBS GROUP AG | 08/14/2025 | 844.78 K | $18.33 M | 11.24% | 0.69% |
JANUS HENDERSON GROUP PLC | 08/14/2025 | 751.56 K | $16.31 M | 134.99% | 0.62% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2025 | 735.70 K | $15.97 M | -24.75% | 0.60% |
BANK OF NEW YORK MELLON CORP | 08/05/2025 | 719.75 K | $15.62 M | 1.38% | 0.59% |
ABRDN PLC | 07/24/2025 | 688.76 K | $14.95 M | -10.00% | 0.56% |
LEGAL & GENERAL GROUP PLC | 08/12/2025 | 663.60 K | $14.40 M | 15.68% | 0.54% |
PACER ADVISORS, INC. | 08/12/2025 | 645.13 K | $14.00 M | -24.49% | 0.53% |
PRINCIPAL FINANCIAL GROUP INC | 08/08/2025 | 623.97 K | $13.54 M | 1.05% | 0.51% |
SWEDBANK AB | 07/10/2025 | 616.13 K | $13.37 M | 0.00% | 0.50% |
UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2025 | 585.67 K | $12.71 M | 11.28% | 0.48% |
METLIFE INVESTMENT MANAGEMENT, LLC | 08/13/2025 | 582.72 K | $12.65 M | -19.52% | 0.48% |
LSV ASSET MANAGEMENT | 08/11/2025 | 577.70 K | $12.54 M | -17.92% | 0.47% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 08/13/2025 | 552.70 K | $11.99 M | -29.76% | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 08/08/2025 | 517.67 K | $11.23 M | 5.95% | 0.42% |
FMR LLC | 08/14/2025 | 509.11 K | $11.05 M | 59.16% | 0.42% |
OBERWEIS ASSET MANAGEMENT INC/ | 08/14/2025 | 468.20 K | $10.16 M | 0.13% | 0.38% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 08/12/2025 | 466.40 K | $10.12 M | 13.55% | 0.38% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2025 | 457.84 K | $9.94 M | -9.60% | 0.37% |
JPMORGAN CHASE & CO | 08/12/2025 | 433.72 K | $9.41 M | 23.03% | 0.36% |
MAN GROUP PLC | 08/14/2025 | 430.90 K | $9.35 M | 45.70% | 0.35% |
MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 430.13 K | $9.33 M | 41.71% | 0.35% |
ORBIMED ADVISORS LLC | 08/14/2025 | 416.90 K | $9.05 M | 100.00% | 0.34% |
GABLES CAPITAL MANAGEMENT INC. | 07/30/2025 | 409.02 K | $8.88 M | -1.77% | 0.33% |
AQR CAPITAL MANAGEMENT LLC | 08/14/2025 | 398.42 K | $8.65 M | -10.57% | 0.33% |
CLARK CAPITAL MANAGEMENT GROUP, INC. | 08/14/2025 | 392.37 K | $8.51 M | 60.15% | 0.32% |
JW ASSET MANAGEMENT, LLC | 08/11/2025 | 388.39 K | $8.43 M | -6.05% | 0.32% |
Catalyst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 452 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Dakota Community Bank & Trust NA: 0
Redhawk Wealth Advisors, Inc.: 0
Inspire Investing, LLC: 0
BlackRock, Inc.: 18.9 M
VANGUARD GROUP INC: 8.77 M
STATE STREET CORP: 5.48 M
82.99% of Catalyst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 123.47 M shares in the last 24 months. This purchase volume represents approximately $2.63 B in transactions.